Skip to main content
main-content

COVID-19 and rheumatic disease

Latest news, guidance, and expert opinion for rheumatology professionals
Spotlight on: COVID-19 in rheumatic disease patients

COVID-19 hospitalization: What do the data tell us?

COVID-19 hospital testing (symbolic image with models)

There were a variety of sessions at the EULAR 2020 E-Congress talking about the risk factors associated with COVID-19 hospitalization among patients with rheumatic conditions, as data from the COVID-19 Global Rheumatology Alliance registry and contributing national registries become available.

Spotlight on: COVID-19 in rheumatic disease patients

Researcher comment: COVID-19 risk factors in RMD patients

Covid-19 infected patient

Pedro Machado discusses data from the COVID-19 Global Rheumatology Alliance registry on the risk factors for COVID-19 hospitalization in patients with rheumatic and musculoskeletal diseases (9:30).

Spotlight on: Guidance for rheumatologists

A closer look at the ACR guidance on COVID-19 and rheumatology care

Ted Mikuls

Ted Mikuls, lead author on the ACR guidance for the management of patients with rheumatic disease during the COVID-19 pandemic, talks about how rheumatologists should best care for their patients at this time and explores some of the unanswered questions (8:08).


Guidance for rheumatologists

Guidance and expert opinion on rheumatology practice during the COVID-19 pandemic


COVID-19 in rheumatic disease patients

The latest research, announcements, and expert interviews on COVID-19 in patients with rheumatic diseases


Repurposing rheumatology drugs for COVID-19

The latest research and announcements on repurposing rheumatology drugs for the treatment of COVID-19

Keep up with podcasts on this topic, available on

Image Credits